Dimitra Stergianou
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Genomic and proteomic insights into hidradenitis suppurativa.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 24, 2025
An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa.
Journal: Expert opinion on biological therapy
Published: April 11, 2024
Impact of Single Nucleotide Polymorphisms of the Promoter of the TNF Gene on Adalimumab Treatment Responses in Hidradenitis Suppurativa.
Journal: Dermatology (Basel, Switzerland)
Published: February 21, 2023
Immune Classification of Hidradenitis Suppurativa: Modulation by Secukinumab.
Journal: The Journal of investigative dermatology
Published: December 28, 2022
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
Journal: Dermatology (Basel, Switzerland)
Published: June 30, 2022
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
Journal: Journal of the American Academy of Dermatology
Published: September 28, 2020
Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab.
Journal: Dermatology (Basel, Switzerland)
Published: June 18, 2020
Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa.
Journal: Expert opinion on drug safety
Published: February 27, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026